The Sync Project’s goal is to develop music as precision medicine through the application of machine learning to a unique dataset combining music characteristics and biometric data. 

The Sync Project is working on initial conditions for human pilot studies including sleep, pain, motor coordination and performance. Development of this kind of personalised music therapy may offer results that traditional and widely prescribed pharmaceutical treatments are unable offer, creating a new era of medicine. 

P&S are honored to be working with The Sync Project on ground breaking territory in generative music and AI alongside exceptional music talent. So far, we’ve helped construct a music advisory board, which consists of legendary visionary artist and producer, Peter Gabriel; Grammy Award-winning alternative artist, Annie Clark (St. Vincent); critically acclaimed electronic musician, Mercury Music Prize and Ivor Novello nominee, Jon Hopkins and distinguished composer and conductor, Esa-Pekka Salonen – all of whom are collaborating with The Sync Project.

“Peter, Annie, Jon and Esa-Pekka are all using technology in creative ways to push the boundaries of what music can be,” said Marko Ahtisaari, The Sync Project’s Co-Founder and CEO. “These extraordinary artists and our other board members and advisors, will help to advance our clinical strategy to develop music as precision medicine.”

“Our senses provide us with different ways of inputting and experiencing ideas and emotions and also provide wonderful opportunities to change our physical and mental health,” said Peter Gabriel. “A good collection of music has always been used as a box of mood pills. I am delighted that The Sync Project is now using evidence-based science to explore and develop real tools and a platform to engage sound and music in the practice of medicine.”

Beyond the advisory board, P&S are engaging artists and producers creatively alongside the deal makers and rights managers to make such musical and medicinal exploration possible.

Watch The Sync Projects CEO Marko Ahtisaari explain it better than we ever could...